Brigatinib - CaLiGraph

CaLiGraph

Property	Value
rdf:type	Receptor tyrosine kinase inhibitor owl:NamedIndividual Cancer treatment Orphan drug Piperidine Organophosphine oxide Aminopyrimidine Drug granted breakthrough therapy designation Takeda Pharmaceutical Company brand
rdfs:label	Brigatinib
owl:sameAs	dbr:Brigatinib
prov:wasDerivedFrom	http://en.wikipedia.org/wiki/Category:Aminopyrimidines http://en.wikipedia.org/wiki/Category:Cancer_treatments http://en.wikipedia.org/wiki/Category:Orphan_drugs http://en.wikipedia.org/wiki/Category:Organophosphine_oxides http://en.wikipedia.org/wiki/Category:Takeda_Pharmaceutical_Company_brands http://en.wikipedia.org/wiki/Category:Piperidines http://en.wikipedia.org/wiki/List_of_drugs_granted_breakthrough_therapy_designation http://en.wikipedia.org/wiki/Category:Receptor_tyrosine_kinase_inhibitors
skos:prefLabel	Brigatinib
skos:altLabel	Brigaix brigatinib
clgo:alternativeName	Alunbrig, others
clgo:casNumber	1197953-54-0
clgo:fdaUniiCode	HYW8DB273J
clgo:kegg	D10866
clgo:medlinePlus	a617016
clgo:pubchem	68165256
is clgo:product of	ARIAD Pharmaceuticals Beacon Pharmaceuticals

About: clgr:Brigatinib